Officials Investigating Anti-Smoking Drug Study
Byline: Audrey Hudson, THE WASHINGTON TIMES
Officials with the Department of Veterans Affairs are preparing to determine who was at fault for failing to quickly notify participants in a smoking-cessation study about the potentially dangerous side effects of a drug they were prescribed and whether the study will be ended.
Dr. Tom Puglisi, chief officer of the VA's Office of Research Oversight, says he has several concerns that veterans suffering from post traumatic stress disorder (PTSD) were prescribed the smoking-cessation drug Chantix without receiving timely written information or warnings about its possible side effects, which can include psychosis and suicidal behavior.
Dr. Puglisi said he also is concerned that similar notification problems exist throughout …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: Officials Investigating Anti-Smoking Drug Study.
Contributors: Not available.
Newspaper title: The Washington Times (Washington, DC).
Publication date: July 20, 2008.
Page number: A02.
© 2009 The Washington Times LLC.
COPYRIGHT 2008 Gale Group.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset